This is perhaps the most exciting new hair loss treatment in development. Currently in Phase 3 clinical trials, pyrilutamide (KX-826) is very close to becoming the first FDA-approved treatment for androgenetic alopecia in decades.
Continue reading Kintor Pyrilutamide (KX-826): The Most Promising Hair Loss Cure in the Pipeline?
